How Wegovy pill now available in Australia compares with weight‑loss injections
Australia's Therapeutic Goods Administration has approved a new tablet version of the weight-loss drug Wegovy. This daily pill offers an alternative to the traditional weekly injections for patients managing obesity or weight-related health conditions.
Why it matters
The introduction of an oral version of GLP-1 medications could significantly increase accessibility and patient compliance for those seeking weight management treatments.
<p>A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia.</p> <p><b>By Kimberley Akrigg, Samuel Cornell and Timothy Piatkowski for The Conversation</b></p> <p>Until now, the best-known medicines in this group (semaglutide, sold as Wegovy or Ozempic, and tirzepatide, sold as Mounjaro), have generally required weekly injections. The new daily tablet offers another option for people who would prefer not to (or can’t) inject themselves.</p> <p>But how does it work? And will swallowing a pill make weight loss easier, cheaper or safer?</p> <h2>What are Wegovy pills, and what’s changed?</h2> <p>Wegovy contains semaglutide, a medicine that copies the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1).
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in